Treace Medical Concepts, Inc. (TMCI) is a Medical - Devices company in the Healthcare sector, currently trading at $2.13. It has a SharesGrow Score of 47/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
Analyst consensus target is TMCI = $3 (+40.8% upside).
Valuation: TMCI trades at a trailing Price-to-Earnings (P/E) of -1.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.19.
Financials: revenue is $213M, +15.1%/yr average growth. Net income is $59M (loss), growing at -7.7%/yr. Net profit margin is -27.7% (negative). Gross margin is 79.8% (-0.8 pp trend).
Balance sheet: total debt is $14M against $87M equity (Debt-to-Equity (D/E) ratio 0.16, conservative). Current ratio is 4.31 (strong liquidity). Debt-to-assets is 7.3%. Total assets: $191M.
Analyst outlook: 2 / 9 analysts rate TMCI as buy (22%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 97/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 54/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
